|
|
Clinical effect of intensive insulin therapy in the treatment of diabetes complicated with acute cerebral infarction |
HUANG Liangzhi HUANG Zugui CHEN Ting |
Department of Endocrinology, the First Hospital of Nanping City, Fujian Province, Nanping 353000, China |
|
|
Abstract Objective To study the clinical effect of intensive insulin therapy in the treatment of diabetes mellitus complicated with acute cerebral infarction. Methods A total of 80 patients with diabetes complicated with acute cerebral infarction in the First Hospital of Nanping City, Fujian Province from January 2019 to January 2021 were selected as the research subjects and divided into an observation group and a control group by the random number table method,with 40 patients in each group. Patients in the control group received conventional treatment, while patients in the observation group received intensive insulin therapy. Blood glucose level, insulin function indicators and neurological deficit were compared between the two groups. Results After treatment, the levels of fasting blood glucose, 2-hour postprandial blood glucose and glycosylated hemoglobin in the observation group were lower than those in the control group, with statistically significant differences (P<0.05). After treatment, fasting insulin and insulin resistance levels in the observation group were lower than those in the control group, with statistically significant differences (P<0.05). The insulin β cells functional level in observation group was higher than that in the control group after treatment, and the difference was statistically significant (P<0.05). After treatment, the score of National Institutes of Health stroke scale in the observation group was lower than that in the control group, the difference was statistically significant (P<0.05).Conclusion Intensive insulin therapy for patients with diabetes complicated with acute cerebral infarction can not only stabilize the blood glucose level of patients, control their insulin resistance, but also improve neurological deficit of patients to a certain extent, with significant therapeutic effect.
|
|
|
|
|
[1] |
蒋召芹,张重阳,李广章,等.探讨胰岛素强化治疗对急诊脑梗塞溶栓患者出血高危因素的影响分析[J].中南医学科学杂志,2019,47(2):143-145,172.
|
[2] |
赵廷启,王铁樵.新诊断2 型糖尿病患者胰岛素强化治疗后三种不同维持方案疗效及安全性的研究[J].中国糖尿病杂志,2020,28(2):112-115.
|
[3] |
訾瑞峰,赵永强,杨海燕.短期胰岛素强化治疗对新诊断2 型糖尿病患者胰岛β 细胞功能及胰岛素抵抗的影响分析[J].医药前沿,2019,9(4):86-87.
|
[4] |
邹丽,姚茂篪,姚平,等.初发2 型糖尿病患者短期胰岛素强化治疗后不同治疗方案对胰岛功能的影响[J].湖北科技学院学报(医学版),2020,34(4):56-58.
|
[5] |
中华医学会糖尿病学分会.中国2 型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
|
[6] |
中华医学会神经病学分会中华医学会神经病学分会脑血管病学组,刘鸣,蒲传强.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246.
|
[7] |
李萌曦,孟凡东,李伟.短期内达格列净片联合胰岛素强化方案对血糖控制不佳的2 型糖尿病患者血糖波动的影响研究[J].世界临床药物,2020,41(11):46-51,56.
|
[8] |
刘烨,朱亦堃,刘炯.基础-餐时胰岛素强化联合西格列汀治疗新诊断2 型糖尿病伴非酒精性脂肪肝的疗效及其对血管内皮功能的影响[J].中西医结合心脑血管病杂志,2020,18(7):1137-1141.
|
[9] |
陈金玉,郭晓霞,曹琳玲.短期胰岛素强化治疗对老年初诊2 型糖尿病患者分泌型卷曲相关蛋白5 的影响[J].中国临床医生杂志,2020,48(1):36-39.
|
[10] |
区洪炎,罗导航,刘娟,等.不同胰岛素强化治疗时间和模式对2 型糖尿病患者胰岛β 细胞功能影响的研究[J].中国糖尿病杂志,2019,27(5):326-330.
|
[11] |
李生俊.糖尿病合并急性脑梗塞患者采取胰岛素强化治疗的疗效观察[J].数理医药学杂志,2021,34(8):1195-1197.
|
[12] |
王科,潘英,贺文麟.急性脑梗塞危险因素及急性脑梗塞与凝血酶激活纤溶抑制物的相关性分析[J].心血管康复医学杂志,2021,30(1):18-21.
|
[13] |
徐汉文,陈华春.老年慢性阻塞性肺疾病急性加重期并发慢性心衰患者血浆同型半胱氨酸水平的变化及意义[J].中国卫生检验杂志,2020,30(13):1607-1609.
|
[14] |
杨硕.浅析依达拉奉联合银杏达莫治疗急性脑梗塞合并2 型糖尿病的临床观察[J].糖尿病天地,2019,16(1):103.
|
[15] |
郎英,刘颖,封宇,等.急性脑梗死患者网膜素-1 水平的动态变化的临床研究[J].中国血液流变学杂志,2019,29(2):166-171.
|
|
|
|